TEMPEST THERAPEUTICS

tempest-therapeutics-logo

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor immunity pathways. The company has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct pathways relevant to mounting an effective anti-tumor response. Tempest Therapeutics was established in 2011 and is headquartered in San Francisco, California.

#SimilarOrganizations #People #Financial #Website #More

TEMPEST THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2011-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.tempesttx.com

Total Employee:
1+

Status:
Active

Contact:
(415) 798-8589

Email Addresses:
[email protected]

Total Funding:
90 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Apache Global Site Tag Microsoft Exchange Online


Similar Organizations

sagimet-biosciences-logo

Sagimet Biosciences

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

synergene-therapeutics-logo

SynerGene Therapeutics

SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics.


Current Advisors List

tom-woiwode_image

Tom Woiwode Board of Directors @ Tempest Therapeutics
Board_member

stella-xu_image

Stella Xu Board of Directors @ Tempest Therapeutics
Board_member

bradley-bolzon_image

Bradley Bolzon Board of Directors @ Tempest Therapeutics
Board_member

robert-weisskoff_image

Robert Weisskoff Board of Directors @ Tempest Therapeutics
Board_member

Current Employees Featured

not_available_image

Anne Moon
Anne Moon Vice President, Project Team Leadership and Project/Portfolio Management @ Tempest Therapeutics
Vice President, Project Team Leadership and Project/Portfolio Management
2019-08-01

jennifer-mcdevitt_image

Jennifer McDevitt
Jennifer McDevitt VP, Clinical Sciences @ Tempest Therapeutics
VP, Clinical Sciences
2017-12-01

not_available_image

Sharon Sakai
Sharon Sakai Senior Vice President, Regulatory & Quality @ Tempest Therapeutics
Senior Vice President, Regulatory & Quality
2019-05-01

thomas-w-dubensky_image

Thomas W. Dubensky
Thomas W. Dubensky President & Founder @ Tempest Therapeutics
President & Founder
2021-06-01

stephen-r-brady_image

Stephen R. Brady
Stephen R. Brady President & COO @ Tempest Therapeutics
President & COO
2019-09-01

chan-whiting_image

Chan Whiting
Chan Whiting SVP Reserch & Developement @ Tempest Therapeutics
SVP Reserch & Developement
2017-01-01

thomas-w-dubensky_image

Thomas W. Dubensky
Thomas W. Dubensky CEO @ Tempest Therapeutics
CEO
2017-09-01

alicia-levey_image

Alicia Levey
Alicia Levey VP, Business Development & Strategy @ Tempest Therapeutics
VP, Business Development & Strategy
2017-09-01

not_available_image

Stephen Brady
Stephen Brady Founder @ Tempest Therapeutics
Founder

Founder


not_available_image

Stephen Brady

thomas-w-dubensky_image

Thomas W. Dubensky

Stock Details


Company's stock symbol is NASDAQ:TPST

Acquisitions List

Date Company Article Price
2021-03-29 Millendo Therapeutics Millendo Therapeutics acquired by Tempest Therapeutics N/A

Investors List

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Post-IPO Equity - Tempest Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Post-IPO Equity - Tempest Therapeutics

foresite-capital_image

Foresite Capital

Foresite Capital investment in Series B - Tempest Therapeutics

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Series B - Tempest Therapeutics

quan-capital_image

Quan Capital

Quan Capital investment in Series B - Tempest Therapeutics

eight-roads-ventures_image

Eight Roads Ventures

Eight Roads Ventures investment in Series B - Tempest Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series B - Tempest Therapeutics

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series B - Tempest Therapeutics

Official Site Inspections

http://www.tempesttx.com Semrush global rank: 4.12 M Semrush visits lastest month: 2.93 K

  • Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
  • IP address: 54.176.110.96
  • Location: San Jose United States
  • Latitude: 37.3388
  • Longitude: -121.8914
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95141

Loading ...

More informations about "Tempest Therapeutics" on Search Engine